Tonix Pharmaceuticals Holding Corp.
509 Madison Avenue, Suite 306
New York, New York 10022
June 20, 2013
United States Securities
and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
|Re:||Tonix Pharmaceuticals Holding Corp.|
|Registration Statement on Form S-1/A|
|File No. 333-186223|
Ladies and Gentlemen:
In accordance with Rule 477 promulgated under the Securities Act of 1933, as amended, Tonix Pharmaceuticals Holding Corp. (the “Company”) hereby requests withdrawal of its Amendment to Registration Statement on Form S-1/A (File No. 333-186223) (the “Amendment”), that was filed with the Securities and Exchange Commission (the “Commission”) on June 6, 2013. The Company requests withdrawal of the Amendment because it was coded with an incorrect Edgar file number. The Company will be resubmitting its filing as an Amendment to Registration Statement on Form S-1/A using the correct Edgar file number of 333-188547.
|TONIX PHARMACEUTICALS HOLDING CORP.|
|By: /s/ SETH LEDERMAN|
|Name: Seth Lederman|
|Title: Chief Executive Officer|